Affymetrix Revenue

Affymetrix revenue was $359.79 m in FY, 2015 which is a 3.1% year over year increase from the previous period.

Embed Graph

Summary - Funding Rounds

Founding Date

1994
Affymetrix is a subsidiary of Thermo Fisher Scientific

Affymetrix Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015

Revenue

267.5m295.6m330.4m349.0m359.8m

Revenue growth, %

6%3%

Cost of goods sold

97.8m116.3m134.0m117.5m110.8m

Gross profit

169.7m179.4m196.4m231.5m249.0m

Gross profit Margin, %

63%61%59%66%69%

Sales and marketing expense

2.0m

R&D expense

63.6m57.9m47.7m50.2m52.9m

General and administrative expense

109.6m142.9m141.4m148.4m149.6m

Operating expense total

186.3m218.5m209.0m229.4m232.3m

EBIT

(16.6m)(39.1m)(12.6m)2.1m16.7m

EBIT margin, %

(6%)(13%)(4%)1%5%

Interest expense

3.8m7.2m12.7m6.4m6.6m

Pre tax profit

(26.8m)(46.5m)(15.2m)(3.6m)10.8m

Income tax expense

1.4m(35.9m)1.2m236.0k733.0k

Net Income

(28.2m)(10.7m)(16.3m)(3.8m)10.1m

Affymetrix Balance Sheet

Quarterly

USDQ2, 2011Q3, 2011Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015

Cash

27.4m32.4m26.7m29.0m37.5m43.7m50.2m57.7m51.5m68.3m104.0m119.6m107.6m

Accounts Receivable

44.6m41.1m53.4m52.5m52.1m47.0m48.5m50.8m49.6m46.0m48.5m52.8m47.8m

Prepaid Expenses

6.5m7.9m14.5m15.1m10.1m8.6m10.1m6.9m6.6m9.0m12.0m9.1m8.6m

Inventories

47.9m47.9m92.0m74.9m74.2m69.2m62.7m57.5m54.0m51.7m50.7m54.0m53.4m

Current Assets

172.8m184.0m198.8m180.2m174.9m169.2m174.7m174.1m163.4m177.0m219.0m239.2m251.1m

PP&E

48.8m45.1m34.1m31.0m25.9m23.3m20.3m17.0m16.9m16.1m18.6m20.9m21.4m

Goodwill

140.3m159.4m158.3m159.1m160.8m161.5m161.2m158.0m151.8m156.8m155.5m

Total Assets

454.2m451.2m588.9m570.2m529.4m512.2m510.6m497.1m478.2m480.6m503.3m538.4m547.3m

Accounts Payable

37.7m40.3m54.7m56.9m49.0m39.0m40.3m49.3m42.9m47.8m43.1m45.9m59.4m

Short-term debt

9.6m9.6m9.6m9.6m12.8m4.0m4.0m4.0m4.0m4.0m

Current Liabilities

47.6m50.0m71.8m77.8m80.7m71.1m72.6m78.4m59.6m64.8m55.9m58.0m70.9m

Long-term debt

95.5m95.5m85.0m82.9m70.1m66.9m105.0m105.0m105.0m105.0m105.0m105.0m105.0m

Total Debt

95.5m95.5m94.6m92.4m79.7m76.5m105.0m12.8m4.0m4.0m4.0m4.0m4.0m

Total Liabilities

230.9m209.4m212.7m202.0m202.9m214.8m

Common Stock

704.0k705.0k706.0k707.0k711.0k714.0k719.0k727.0k732.0k736.0k773.0k798.0k799.0k

Additional Paid-in Capital

746.0m748.2m755.0m757.1m761.4m763.2m765.0m771.5m776.4m778.4m812.4m840.4m843.1m

Retained Earnings

(454.2m)(464.0m)(452.0m)(477.1m)(504.8m)(510.9m)(515.1m)(516.2m)(517.1m)(514.7m)(505.2m)(498.2m)(503.5m)

Total Equity

295.2m287.8m306.0m285.1m261.3m257.8m257.6m266.2m268.9m267.9m301.3m335.5m332.5m

Debt to Equity Ratio

0 x0 x0 x0 x0 x0 x

Debt to Assets Ratio

0 x0 x0 x0 x0 x0 x

Financial Leverage

1.5 x1.6 x1.9 x2 x2 x2 x2 x1.9 x1.8 x1.8 x1.7 x1.6 x1.6 x

Affymetrix Cash Flow

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015

Net Income

(28.2m)(10.7m)(16.3m)(3.8m)10.1m

Depreciation and Amortization

32.3m36.1m39.0m30.7m21.8m

Accounts Receivable

8.3m(514.0k)2.3m2.8m(12.0m)

Inventories

6.5m12.0k2.5m603.0k(1.1m)

Accounts Payable

(448.0k)(21.7m)(816.0k)8.8m2.4m

Cash From Operating Activities

39.3m3.7m53.6m43.5m36.5m

Purchases of PP&E

(5.8m)(8.2m)(4.8m)(7.9m)(10.5m)

Cash From Investing Activities

127.6m(258.9m)15.7m(4.7m)(73.2m)

Cash From Financing Activities

(486.0k)78.5m(37.9m)(15.3m)46.1m

Net Change in Cash

166.5m(176.3m)31.5m22.8m8.8m

Interest Paid

3.3m(7.0m)12.5m5.4m4.8m

Income Taxes Paid

633.0k3.9m(2.2m)

Affymetrix Ratios

USDQ2, 2011

Financial Leverage

1.5 x